These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 27094260)

  • 21. Vaccination with LetiFend® reduces circulating immune complexes in dogs experimentally infected with L. infantum.
    Cacheiro-Llaguno C; Parody N; Renshaw-Calderón A; Osuna C; Alonso C; Carnés J
    Vaccine; 2020 Jan; 38(4):890-896. PubMed ID: 31706810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis.
    Reis AB; Giunchetti RC; Carrillo E; Martins-Filho OA; Moreno J
    Trends Parasitol; 2010 Jul; 26(7):341-9. PubMed ID: 20488751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of Host Immune Response during
    Sanz CR; Miró G; Sevane N; Reyes-Palomares A; Dunner S
    Front Immunol; 2021; 12():794627. PubMed ID: 35058931
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmania infantum-specific IFN-γ production in stimulated blood from dogs with clinical leishmaniosis at diagnosis and during treatment.
    Martínez-Orellana P; Marí-Martorell D; Montserrat-Sangrà S; Ordeix L; Baneth G; Solano-Gallego L
    Vet Parasitol; 2017 Dec; 248():39-47. PubMed ID: 29173539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical management of canine leishmaniosis versus human leishmaniasis due to Leishmania infantum: Putting "One Health" principles into practice.
    Miró G; López-Vélez R
    Vet Parasitol; 2018 Apr; 254():151-159. PubMed ID: 29657002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of canine leishmaniosis vaccination with Canileish® in Leishmania infantum infection seroprevalence studies.
    Velez R; Domenech E; Cairó J; Gállego M
    Acta Trop; 2020 Feb; 202():105259. PubMed ID: 31703952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine β-defensin-1 (CBD1) gene as a possible marker for Leishmania infantum infection in dogs.
    da Silva LG; Costa-Júnior CRL; Figueiredo-Júnior CAS; Leal-Balbino TC; Crovella S; Otranto D; Balbino VQ; Dantas-Torres F
    Parasit Vectors; 2017 Apr; 10(1):199. PubMed ID: 28427438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic vaccine of killed Leishmania amazonensis plus saponin reduced parasite burden in dogs naturally infected with Leishmania infantum.
    Viana KF; Lacerda G; Teixeira NS; Rodrigues Cangussu AS; Sousa Aguiar RW; Giunchetti RC
    Vet Parasitol; 2018 Apr; 254():98-104. PubMed ID: 29657019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary vaccination with the LiESP/QA-21 vaccine (CaniLeish) produces a cell-mediated immune response which is still present 1 year later.
    Moreno J; Vouldoukis I; Schreiber P; Martin V; McGahie D; Gueguen S; Cuisinier AM
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):199-207. PubMed ID: 24560650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gentamicin-attenuated Leishmania infantum vaccine: protection of dogs against canine visceral leishmaniosis in endemic area of southeast of Iran.
    Daneshvar H; Namazi MJ; Kamiabi H; Burchmore R; Cleaveland S; Phillips S
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2757. PubMed ID: 24743691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cross-sectional study of the impact of regular use of insecticides in dogs on Canine Leishmaniosis seroprevalence in southeast Spain.
    Goyena E; Pérez-Cutillas P; Chitimia L; Risueño J; García-Martínez JD; Bernal LJ; Berriatua E
    Prev Vet Med; 2016 Feb; 124():78-84. PubMed ID: 26743595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of intracellular IFN-γ and IL-4 cytokines in CD4+ and CD8+ T cells in the peripheral blood of dogs naturally infected with Leishmania infantum.
    Matralis D; Papadogiannakis E; Kontos V; Papadopoulos E; Ktenas E; Koutinas A
    Parasite Immunol; 2016 Aug; 38(8):510-5. PubMed ID: 27153749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend® against canine leishmaniosis.
    Fernández Cotrina J; Iniesta V; Monroy I; Baz V; Hugnet C; Marañon F; Fabra M; Gómez-Nieto LC; Alonso C
    Vaccine; 2018 Apr; 36(15):1972-1982. PubMed ID: 29525281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptors and cytokines in the brain and in spleen of dogs with visceral leishmaniosis.
    Grano FG; Dos S Silva JE; Melo GD; de Souza MS; Lima VMF; Machado GF
    Vet Parasitol; 2018 Apr; 253():30-38. PubMed ID: 29605000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A further investigation of the leishmaniosis outbreak in Madrid (Spain): low-infectivity phenotype of the Leishmania infantum BOS1FL1 isolate to establish infection in canine cells.
    Mas A; Martínez-Rodrigo A; Orden JA; Viñals LM; Domínguez-Bernal G; Carrión J
    Vet Immunol Immunopathol; 2020 Dec; 230():110148. PubMed ID: 33189999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Awareness and control of canine leishmaniosis: A survey among Spanish and French veterinarians.
    Le Rutte EA; van Straten R; Overgaauw PAM
    Vet Parasitol; 2018 Apr; 253():87-93. PubMed ID: 29605010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leishmania infantum exerts immunomodulation in canine Kupffer cells reverted by meglumine antimoniate.
    Rodrigues A; Santos-Mateus D; Alexandre-Pires G; Valério-Bolas A; Rafael-Fernandes M; Pereira MA; Ligeiro D; de Jesus J; Alves-Azevedo R; Lopes-Ventura S; Santos M; Tomás AM; Pereira da Fonseca I; Santos-Gomes G
    Comp Immunol Microbiol Infect Dis; 2017 Dec; 55():42-52. PubMed ID: 29127992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.